M I Marks. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » AerosolsAnti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/therapeutic useBronchitis/etiologyBronchopneumonia/etiologyCeftazidime/therapeutic useCystic Fibrosis/complicationsHumansInfantInfant, NewbornPrognosisPseudomonas Infections/drug therapyRespiratory Tract Infections/etiology
Substances： See more » AerosolsAnti-Bacterial AgentsCeftazidime
Year: 1986 PMID： 3512813 DOI： 10.1016/s0022-3476(86)80908-8
Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406